Orbem
Health
· Headquartered in Germany 🇩🇪
Track Orbem
— get Health deals in free daily digest
Overview
Munich-based Orbem has raised €55.5 million in a Series B funding round led by Innovation Industries, with participation from Supernova Invest and existing investors. Orbem utilizes AI to industrialize magnetic resonance imaging for non-invasive analysis of biological materials, addressing challenges in agriculture, food production, and health. Their flagship product, Genus Focus, determines the sex of poultry eggs rapidly, offering a humane alternative to culling. The funding will support U.S. expansion and entry into the fruit and vegetable sector.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
Investors: Innovation Industries, Supernova Invest
Munich-based Orbem has raised €55.5 million in a Series B funding round led by Innovation Industries, with participation from Supernova Invest and existing investors. Orbem utilizes AI to industrialize magnetic resonance imaging for non-invasive analysis of biological materials, addressing challenges in agriculture, food production, and health. Their flagship product, Genus Focus, determines the sex of poultry eggs rapidly, offering a humane alternative to culling. The funding will support U.S. expansion and entry into the fruit and vegetable sector.
More Health Deals
Market Map
View thousands of companies by category in our market map:
